The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.
Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
All participants must be 18 years of age or older.
Subjects may be any stage and anywhere in the treatment continuum.
Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
Any patient who cannot understand written or spoken English.
Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
Any patient on a treatment clinical trial.
Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
patients receiving cancer treatment for breast, lung, GI or multiple myeloma
Other
Prospective
Web based survey
Other interventiononline weekly survey
Create Data Set
The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment
Click on the lead sponsor to view all of their trials.
